Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-439,946
Closed -$3.82M 648
2025
Q4
$3.82M Buy
439,946
+261,737
+147% +$2.27M 0.3% 112
2025
Q3
$1.67M Buy
+178,209
New +$1.66M 0.13% 188
2023
Q2
Sell
-32,118
Closed -$509K 286
2023
Q1
$509K Buy
+32,118
New +$557K 0.28% 101
2022
Q4
Sell
-90,453
Closed -$1.77M 218
2022
Q3
$1.77M Sell
90,453
-118,193
-57% -$2.58M 0.62% 39
2022
Q2
$3.66M Buy
+208,646
New +$3.78M 1.6% 7
2020
Q2
Sell
-16,883
Closed -$130K 390
2020
Q1
$130K Buy
16,883
+4,497
+36% +$38.4K 0.01% 276
2019
Q4
$123K Buy
+12,386
New +$118K 0.01% 233

Other funds holding ADTN

Atom Investors's ADTN Position: Q1 2026 in Review

Atom Investors sold out of Adtran (ADTN) in Q1 2026, closing a stake of 439,946 shares — an estimated $3.82M sold.

Atom Investors first reported a position in ADTN in Q4 2019 and held it in 7 quarters. The position peaked at $3.82M in Q4 2025. 227 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

  • Atom Investors reported no remaining Adtran position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 439,946 Adtran shares in Q1 2026, an estimated $3.82M.
  • Atom Investors first reported a position in Adtran in Q4 2019 and held it in 7 quarters.
  • Atom Investors's Adtran position peaked at $3.82M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.